Related Site
CES Videos
Life Sciences Panel, 45:04 mins
Life Sciences Panel: Q&A, 19:37 mins
February 21, 2004
Jonathan J. MacQuitty, Abingworth Management
Craig Taylor, Alloy Ventures
Barbara Santry, Capstone Ventures
Geoffrey Duyk, TPG
Mark Edwards, Recombinant Capital (Moderator)
This panel of leading Silicon Valley venture capitalists discussing Lifescience investing gives a rich snapshot of developments in the field between 2002 and 2004. The panel covers current and historical trends in public and private investing in biotechnology and medical devices, where Sand Hill is investing and what it looks for in a management team, the impact of liquidation preferences on VC investing and exit opportunities, management incentives and the impact of dilution, the importance of product differentiation, the role of the FDA in life sciences, and entrepreneurship in the context of changes in the broader U.S. health care system.
For best audio and video quality, please use RealOne PlayerTM which plays all major media formats, including QuickTime, MPEG, and Windows Media. A free version of the media player is available to download. If after downloading you have problems, please contact the Center at ces@gsb.stanford.edu
Return to Video Search